The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA(1C) in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study

INTRODUCTION: Sodium glucose co-transporter 2 (SGLT2) inhibitors increase urinary glucose excretion (UGE) by reducing the renal threshold for glucose excretion, which results in decreased serum glucose concentrations in patients with type 2 diabetes mellitus (T2D). However, no study to date has dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, So Ra, Lee, Yong-ho, Kang, Eun Seok, Cha, Bong-Soo, Lee, Byung-Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446375/
https://www.ncbi.nlm.nih.gov/pubmed/28332143
http://dx.doi.org/10.1007/s13300-017-0248-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446375/
https://www.ncbi.nlm.nih.gov/pubmed/28332143
http://dx.doi.org/10.1007/s13300-017-0248-5

Ejemplares similares